The KDIGO Onco-Nephrology Conference will gather a global panel of multidisciplinary clinical and scientific expertise (e.g., nephrology, oncology, intensive care, hematology pharmacology, etc.) who will identify key management issues in nephrology relevant to patients with malignancy. It is understood that the development of newer and more effective cancer treatments has led to an increasing number of cancer survivors but unfortunately many of these treatments can be nephrotoxic. As such, prevention, early detection, long-term monitoring and treatment of ensuing problems in these patients is a growing problem.
Drs. Jolanta Małyszko (Warsaw Medical University, Warsaw, Poland) and Camillo Porta (IRCCS San Matteo University Hospital Foundation, Pavia, Italy) will co-chair this conference.
KDIGO makes preliminary Scope of Work documents available for public review prior to final planning of any Controversies Conference. To this end, we cordially invite your input on the Onco-Nephrology Conference Scope of Work which can be found in the Resources section. Kindly submit your comments via the feedback form below no later than Monday, November 12th.